← Leaderboards
Xu Chen
J. David Gladstone Institutes
$4,825,509
Attributed
$5,115,092
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,115,092 · 4
By mechanism
R01$4,414,173 · 2
R21$434,375 · 1
K99$266,544 · 1
Top collaborators
- Gourisankar Ghosh1 shared
- Sushil K Mahata1 shared
Most similar at J. David Gladstone Institutes
Same institution · by research overlap
- Melanie Maria Ott$58,597,956
- Keith Alan Vossel$8,162,807
- Eric M Verdin$53,862,857
- Tara Tracy$5,075,828
- Steven M Finkbeiner$50,309,699
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposTau ProteinsNeuronsAffectS DiseaseBrainMouse ModelPathway InteractionsLinkTauopathiesPathogenesisRegulationMolecularMediatingNeurodegenerative DisordersMetabolismProtective EffectImpaired CognitionGeneticSignal TransductionCognitive FunctionPathologicResponseTransgenic Mice
Grant awards (11)
Mechanisms by which the ketone body β-hydroxybutyrate counteracts tau pathogenesis$567,208
R01 · FY2025 · AG · contact PI
Role of Testosterone in Modulating Tau Pathogenesis in Females$555,082
R01 · FY2025 · AG · contact PI
Role of Testosterone in Modulating Tau Pathogenesis in Females$534,810
R01 · FY2024 · AG · contact PI
Mechanisms by which the ketone body β-hydroxybutyrate counteracts tau pathogenesis$527,335
R01 · FY2024 · AG · contact PI
Mechanisms by which the ketone body β-hydroxybutyrate counteracts tau pathogenesis$586,683
R01 · FY2023 · AG · contact PI
Role of Testosterone in Modulating Tau Pathogenesis in Females$566,410
R01 · FY2023 · AG · contact PI
Mechanisms by which the ketone body β-hydroxybutyrate counteracts tau pathogenesis$541,835
R01 · FY2022 · AG · contact PI
Role of Testosterone in Modulating Tau Pathogenesis in Females$534,810
R01 · FY2022 · AG · contact PI
The Role of Chromogranin A in Tauopathy$434,375
R21 · FY2021 · AG
Metabolic Regulation of Neurodegeneration in Tauopathy$133,272
K99 · FY2017 · AG · contact PI
Metabolic Regulation of Neurodegeneration in Tauopathy$133,272
K99 · FY2016 · AG · contact PI